Craig-Hallum Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $24

Craig-Hallum analyst Adam Vogel has initiated coverage on Satellos Bioscience (NASDAQ: MSLE) with a Buy rating. The firm has set a price target of $24 for the company's stock.